Large Language Models
Feb 5, 2026
GPT-5 and Ginkgo Bioworks reduce cell-free protein synthesis costs by 40%
Feb 5, 2026
AI Summary
A collaboration between OpenAI's GPT-5 and Ginkgo Bioworks has led to a significant reduction in the costs associated with cell-free protein synthesis. This was achieved through the use of closed-loop experimentation in an autonomous lab setting.
- OpenAI's GPT-5 was integrated with Ginkgo Bioworks' cloud automation technology.
- The combination resulted in a 40% decrease in costs for cell-free protein synthesis.
- The reduction in costs was made possible through closed-loop experimentation techniques.